These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24885776)

  • 21. Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice.
    Bai Y; Gong H; Li H; Vu GP; Lu S; Liu F
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3222-7. PubMed ID: 21300908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.
    Zou H; Lee J; Umamoto S; Kilani AF; Kim J; Trang P; Zhou T; Liu F
    J Biol Chem; 2003 Sep; 278(39):37265-74. PubMed ID: 12867424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General design and construction of RNase P ribozymes for gene-targeting applications.
    Zou H; Chan K; Trang P; Liu F
    Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of an M1GS Ribozyme for Targeted and Rapid mRNA Cleavage; Application on the Ets-2 Oncogene.
    Toumpeki C; Anastasakis D; Panagoulias I; Stamatopoulou V; Georgakopoulos T; Kallia-Raftopoulos S; Mouzaki A; Drainas D
    Med Chem; 2018; 14(6):604-616. PubMed ID: 29332592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins.
    Yang Z; Reeves M; Ye J; Trang P; Zhu L; Sheng J; Wang Y; Zen K; Wu J; Liu F
    Viruses; 2015 Jun; 7(7):3345-60. PubMed ID: 26114473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme.
    Zeng W; Chen YC; Bai Y; Trang P; Vu GP; Lu S; Wu J; Liu F
    PLoS One; 2012; 7(12):e51855. PubMed ID: 23300569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate.
    Hsu AW; Kilani AF; Liou K; Lee J; Liu F
    Nucleic Acids Res; 2000 Aug; 28(16):3105-16. PubMed ID: 10931926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate.
    Trang P; Hsu AW; Liu F
    Nucleic Acids Res; 1999 Dec; 27(23):4590-7. PubMed ID: 10556315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.
    Li W; Liu Y; Wang Y; Li R; Trang P; Tang W; Yang Z; Wang Y; Sun X; Xing X; Lu S; Liu F
    Theranostics; 2018; 8(20):5634-5644. PubMed ID: 30555569
    [No Abstract]   [Full Text] [Related]  

  • 31. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.
    Trang P; Lee J; Kilani AF; Kim J; Liu F
    Nucleic Acids Res; 2001 Dec; 29(24):5071-8. PubMed ID: 11812839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
    Sun X; Chen W; He L; Sheng J; Liu Y; Vu GP; Yang Z; Li W; Trang P; Wang Y; Hai R; Zhu H; Lu S; Liu F
    PLoS One; 2017; 12(10):e0186791. PubMed ID: 29059242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribozyme-Mediated Downregulation Uncovers DNA Integrity Scanning Protein A (DisA) as a Solventogenesis Determinant in
    Ujor VC; Lai LB; Okonkwo CC; Gopalan V; Ezeji TC
    Front Bioeng Biotechnol; 2021; 9():669462. PubMed ID: 34169065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA.
    Macejak DG; Jensen KL; Pavco PA; Phipps KM; Heinz BA; Colacino JM; Blatt LM
    J Viral Hepat; 2001 Nov; 8(6):400-5. PubMed ID: 11703570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA.
    Zou H; Lee J; Kilani AF; Kim K; Trang P; Kim J; Liu F
    J Biol Chem; 2004 Jul; 279(31):32063-70. PubMed ID: 15169770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geneticin Stabilizes the Open Conformation of the 5' Region of Hepatitis C Virus RNA and Inhibits Viral Replication.
    Ariza-Mateos A; Díaz-Toledano R; Block TM; Prieto-Vega S; Birk A; Gómez J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):925-35. PubMed ID: 26621620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells.
    Bai Y; Li H; Vu GP; Gong H; Umamoto S; Zhou T; Lu S; Liu F
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7269-74. PubMed ID: 20360564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Amplification and Selection of Engineered RNase P Ribozyme for Gene Targeting Applications.
    Trang P; Zhang I; Liu F
    Methods Mol Biol; 2024; 2822():419-429. PubMed ID: 38907932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first phytoplasma RNase P RNA provides new insights into the sequence requirements of this ribozyme.
    Wagner M; Fingerhut C; Gross HJ; Schön A
    Nucleic Acids Res; 2001 Jun; 29(12):2661-5. PubMed ID: 11410676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.